109 related articles for article (PubMed ID: 4383687)
1. The synthesis of benzimidazole derivatives as potential antihistaminic compounds.
Deshpande SM; Nain K
Bull Chem Soc Jpn; 1967 Apr; 40(4):988-9. PubMed ID: 4383687
[No Abstract] [Full Text] [Related]
2. Bioisosteric transformation of H1-antihistaminic benzimidazole derivatives.
Iemura R; Hori M; Saito T; Ohtaka H
Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2723-6. PubMed ID: 2575462
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents.
Iemura R; Kawashima T; Fukuda T; Ito K; Tsukamoto G
J Med Chem; 1986 Jul; 29(7):1178-83. PubMed ID: 2879912
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of benzimidazole derivatives with potential antihistaminic activity.
Rida SM; el-Dine SA; Labouta IM
Pharmazie; 1977 Oct; 32(10):577-9. PubMed ID: 24226
[No Abstract] [Full Text] [Related]
5. Syntheses of the metabolites of 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H benzimidazole difumarate (KG-2413) and related compounds.
Iemura R; Hori M; Ohtaka H
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):962-6. PubMed ID: 2569942
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of a new series of benzimidazoles as H1-antihistaminic agents.
Cuberes MR; Contijoch M; Calvet C; Alegre J; Quintana JR; Frigola J
Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1287-92. PubMed ID: 9301027
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationships of H1-antihistaminic benzimidazole derivatives.
Iemura R; Ohtaka H
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):967-72. PubMed ID: 2569943
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
[TBL] [Abstract][Full Text] [Related]
9. 4-(Indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds.
Freter K; Fuchs V; Barsumian E; Oliver JT
Arzneimittelforschung; 1985; 35(1A):272-6. PubMed ID: 2580540
[TBL] [Abstract][Full Text] [Related]
10. The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomnia.
Lavrador-Erb K; Ravula SB; Yu J; Zamani-Kord S; Moree WJ; Petroski RE; Wen J; Malany S; Hoare SR; Madan A; Crowe PD; Beaton G
Bioorg Med Chem Lett; 2010 May; 20(9):2916-9. PubMed ID: 20347297
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and pharmacological properties of new 2-aminobenzimidazole derivatives.
Nawrocka W
Boll Chim Farm; 1996 Jan; 135(1):18-23. PubMed ID: 9004736
[TBL] [Abstract][Full Text] [Related]
12. Optically active analogues of ebastine: synthesis and effect of chirality on their antihistaminic and antimuscarinic activity.
Zhang MQ; Walczynski K; Ter Laak AM; Timmerman H
Chirality; 1994; 6(8):631-41. PubMed ID: 7857774
[TBL] [Abstract][Full Text] [Related]
13. [Comparative experimental and clinical investigations of new antihistaminic drugs of the benzimidazole type].
KIMMIG J
Hautarzt; 1952 Sep; 3(9):414-6. PubMed ID: 12999083
[No Abstract] [Full Text] [Related]
14. [Synthesis of hexahydro-1,4-diazepine derivatives with potential pharmacological effects. IV. Synthesis and studies on the antihistaminic activity of hexahydro-1,4-diazepine derivatives containing ether groups].
Guryn R; Kotełko A; Majchrzak M; Szadowska A; Wejman I
Acta Pol Pharm; 1980; 37(1):53-8. PubMed ID: 6104893
[No Abstract] [Full Text] [Related]
15. Design and synthesis of novel 3-(4-chlorophenyl)-2-(3-substituted propyl thio) quinazolin-4-(3H)-ones as a new class of H1-antihistaminic agents.
Alagarsamy V; Parthiban P
Arzneimittelforschung; 2012 Sep; 62(9):433-8. PubMed ID: 22855299
[TBL] [Abstract][Full Text] [Related]
16. [4-[Benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds with selective antagonistic activity against H1-histamine receptors].
Mossini F; Maggiali C; Morini G; Impicciatore M; Morini G; Molina E
Farmaco Sci; 1984 Mar; 39(3):189-99. PubMed ID: 6143687
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and pharmacological screening of a series of N1-(substituted) aryl-5,7-dimethyl-2-(substituted)pyrido(2,3-d)-pyrimidin-4(3H)-ones as potential histamine H1-receptor antagonists.
Suhagia BN; Chhabria MT; Makwana AG
J Enzyme Inhib Med Chem; 2006 Dec; 21(6):681-91. PubMed ID: 17252940
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new 2-substituted-[1,3,4]-oxadiazino-[6,5-b]-indoles with H1-antihistaminic, antimuscarinic and antimicrobial activity [corrected].
Ajitha M; Rajnarayana K; Sarangapani M
Pharmazie; 2002 Dec; 57(12):796-9. PubMed ID: 12561237
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1-(N-phenyl-N-arylmethyl)cyclohexylmethylamines of potential analgesic and antihistaminic activities.
Aboul-Enein MN; el-Azzouny AA
Acta Pharm Suec; 1983; 20(6):461-6. PubMed ID: 6144236
[No Abstract] [Full Text] [Related]
20. Synthesis and H1-antihistaminic activity of beta-alkoxyethyl and beta-(N,N-dialkylamino)ethyl-(3-aryl-3,4-dihydro-4-oxoquinazolin- 2-yl)m ethyl ethers.
Rao AR; Reddy VM
Pharmazie; 1992 Oct; 47(10):794-6. PubMed ID: 1362273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
